Atlas Trials

A Proof of Concept Study of Maintenance Therapy With Tasquinimod in Patients With Metastatic Castrate-resistant Prostate Cancer Who Are Not Progressing After a First Line Docetaxel Based Chemotherapy

Clinical trial NCT01732549 · TERMINATED

Trial details

NCT number
NCT01732549
Sponsor
Ipsen
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Metastatic Castrate Resistant Prostate Cancer
Start date
2013-01-01
Primary completion
2015-02-01
Enrollment
144

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.